Background: Hydra-headed clinical presentations of tuberculosis could be confusing even in immunocompetent, for example pleuro-pericardial effusion with adenitis. From our literature search, this is rare.
Introduction
Tuberculosis (TB) remains a clinical challenge in developing countries; be its diagnosis, treatment and prevention (primary and secondary). Globally, incidence of TB is increasing due to HIV pandemic, multi-drug resistance and excruciating socio-economic melt-down. Africa, Asia and Latin America account for 98% of nearly two million deaths resulting from tuberculosis each year [1] . Its clinical presentations could be hydra-headed. Up to 4% of cases
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of acute pericarditis and 7% of cardiac tamponade are due to tuberculosis with a mortality rate of 14-40% [2] . We present a case of tuberculous pleuro-pericardial effusion with adenitis in an apparently immunocompetent clergyman.
Clinical History
A 61-year-old clergyman presented with a 3-week history of cough, fever and a 5-day history of progressive difficulty with breathing. Cough was non-productive and no associated chest pain or hemoptysis. He had a high grade fever, intermittent but no drenching night sweat. The cough and fever subsided with paracetamol, antimalarial drugs and antibiotic (Amoxycillin) given at a mission hospital. However, he later developed progressive dyspnoea. No orthopnoea, paroxysmal nocturnal dyspnoea, abdominal discomfort or change in bowel habit, early satiety or leg swelling. There was anorexia and weight loss. He was not a known diabetes mellitus or hypertensive patient; neither previously treated for tuberculosis nor on any medication for a chronic illness. He was married in a monogamous setting with children and neither smoked cigarette nor drank alcohol. A month prior to onset of the current problems, he was treated for left axillary furuncle at a mission hospital. With onset of dyspnoea, he was admitted but referred to our facility after 4 days of worsening clinical state. 
Discussion
Our patient had tuberculous hemorrhagic pleural effusion with concomitant pericardial effusion and left axillary adenitis. Pericardial involvement in TB which occurs in 1-8% of cases is a clinically important TB extra-pulmonary manifestation [3] . Extra-pulmonary involvement occurs in 20% of cases and this increases to 50% in HIV infected population [3, 4] . Pericardial spread could be from lung parenchymal, mediastinal or hilar lymph nodes, as part of miliary dissemination of the tubercle or rarely directly from tuberculous pneumonia. Presence of adenitis with serous effusion is significant. Large pericardial effusion is associated with adenitis but small effusion results from hematogenous spread [5] .
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Chest radiograph showed an enlarged cardiac silhouette suggestive of pericardial effusion with no active lung parenchymal disease. 90% of cases of tuberculous pericarditis show cardiomegaly on chest radiography but only 30% shows active lung disease according to Mayosi et al [6] . ECG revealed a 3 rd degree atrioventricular (AV) block.
Nearly all cases of tuberculous pericarditis have abnormal ECG [6] . Tuberculous pericarditis is less commonly identified as a cause of 3 rd degree AV block, unlike other infectious causes like infective endocarditis, Chaga's disease, Lyme's disease. Of note was the narrow complex escape rhythm (accelerated junctional escape rhythm at a rate of 62 bpm).
The definite diagnosis of tuberculous pericarditis was by positive AFB in the pleural aspirate and typical lymph node histology, in keeping with criteria by Mayosi et al [6] . As timely intervention in tuberculous pericarditis could be life saving, its accurate diagnosis which is often difficult should be rapid [7] . This is the situation in our case as the patient presented at a hospital where he was managed for pneumonia and left axillary boils but referred late to our facility resulting in his demise even before comprehensive pathological results came out let alone commencement of anti-tuberculosis therapy. 
Conclusion
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